Fundraising FoxDilafor
Stockholm, SE · 1 known investors
Find your way into Dilafor
Sign up to see every warm intro you have to Dilafor
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Dilafor team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Dilafor is a clinical-stage pharmaceutical company developing tafoxiparin, a proprietary heparan sulfate mimetic drug candidate intended to improve cervical ripening and support efficient labor in term pregnant women. The drug aims to reduce complications associated with planned start of labor, and is based on research from Karolinska Institute and Lund University.
Investors · 1
Frequently asked questions
- What does Dilafor do?
- Dilafor is a clinical-stage pharmaceutical company developing tafoxiparin, a proprietary heparan sulfate mimetic drug candidate intended to improve cervical ripening and support efficient labor in term pregnant women. The drug aims to reduce complications associated with planned start of labor, and is based on research from Karolinska Institute and Lund University.
- Who are Dilafor's investors?
- Dilafor's investors include Rosetta Capital Ltd..
- Where is Dilafor headquartered?
- Dilafor is headquartered in Stockholm, SE.